Circulating Tumor Cells (CTCs) Prognostic Technologies Market

Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Global circulating Tumor Cells Market: Snapshot

The global circulating tumor cells prognostic technologies market are rising in demand due to increasing demand for diagnostic technologies. This rise in demand for these technologies are primarily due to prevalence rate of cancer. Huge application scope of these technologies are dependent on safety of patients. Substantial Rise in therapeutic monitoring is rising the demand for the market. Increased death rates due to development of metastases and hematogenous dissemination of cancer is also boosting the need for detection of circulating tumor cells. Novel technologies for detection of circulating tumor cells are rising in demand due to many clinical trials including them as their secondary end points and in their translation research programs. The global market is expecting wider implementation possibilities of circulating tumor cells prognostic technologies in the coming years due to increasing rate of research and development activities conducted for developing personalized medicines.

According to a report by Transparency Market Research, the global circulating tumor cells prognostic technologies market is anticipated to rise at a tremendous CAGR of 26.30% during the forecast period of 2014 to 2020. The global market value is expected to attain a valuation of US$2.16 bn by the end of the forecast period.

Rise in Breast Cancer to Supplement Application of Technology with CAGR of 27.10% by 2020

The global circulating tumor cells prognostic technologies market have been segmented according to technology and applications. Technology segment is further sub segmented into tumor cell enrichment and tumor cell detection. The tumor cell detection segment is further bifurcated into molecular method and optical method. Among these, optical method segment is anticipated to rise at a rising CAGR of 27.30% during the forecast period of 2014 to 2020. The tumor cell enrichment is further sub segmented into immunomagnetic method and immunological method, centrifugation, and filtration. Among these sub segments, immunomagnetic method will account for the largest share in the tumor cell enrichment segment.

The global circulating tumor cells prognostic technologies by application is segmented into prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, lung cancer, and ovarian cancer. Among these sub segments, prostate cancer is expected to rise at a significant CAGR of 25.20% during forecast period whereas, the breast cancer segment is anticipated to reach 27.10% CAGR by the end of 2020. Rise in breast cancer is accounting for a significant share in the market and is expected to rise in the coming years.

Increasing Prognostic Technologies to Boost North America Market

The global circulating tumor cells prognostic technologies market is spread across various regions such as North America, Asia pacific, Europe, and the rest of the world. Among these, North America is holding the largest shares in the market due to increased incidence and prevalence of cancer. The market in this region is also dominating the market due to increased adoption rate of advanced prognostic technologies. North America has disposable income that people are willing to spend on healthcare thus, it boosts the market in this region. Government’s extensive support for research and development in this region is supplementing the market growth of North America.

Similarly, Asia Pacific is also experiencing significant growth rate in the market. This region is experiencing steady growth in the market due to rise in various types of cancers among the people. The key players and government of various countries in this region is encouraging research and development activities to produce better technologies. Innovations have led to increased adoption rate of advanced therapeutic monitoring technologies in this region. Rise in population has resulted in rise of different types of cancer. Emerging economies in this region are showing potential rise in advancement and implication of the technologies.

Some of the key players operating in the circulating tumor cells prognostic technologies market are Epic Science, Silicon Biosystems, Vitatex, Veridex, and AVIVA Biosciences Corp.

     
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Market Segmentation
    1.3 Research Methodology
     
    Chapter 2 Executive Summary
    2.1 Market Snapshot: Global CTCs Prognostic Technologies Market
    2.2 Comparative Analysis: Global CTCs Prognostic Technologies Market, by Geography, 2013 & 2020 (Value %)
     
    Chapter 3 Global CTCs Prognostic Technologies Market Overview
    3.1 Market Dynamics and Overview
    3.1 Market Drivers
          3.1.1 Escalating Prevalence Rate of Cancer
          3.1.2 High Cost-benefit Ratio
          3.1.3 Increased Evaluation of Therapeutic Monitoring
          3.1.4 Technological Development
    3.2 Market Restraints
          3.2.1 High Pricing Associated with CTCs Detection
          3.2.2 Lack of Specificity and Sensitivity
          3.2.3 Reluctance in Adopting Advanced Prognostic Technologies 
    3.3 Market Opportunities
          3.3.1 Strengthening Distribution Network In Emerging Markets
          3.3.2 Development of Personalized Medicines based on CTCs
    3.4 Porter’s Five Forces Analysis
          3.4.1 Bargaining Power of Suppliers
          3.4.2 Bargaining Power of Buyers
          3.4.3 Threat of Substitutes
          3.4.4 Threat of New Entrants
          3.4.5 Competitive Rivalry
    3.5 Event Impact Analysis (Historical Trends and Future Outlook), 2012 – 2020
    3.6 Market Attractiveness Analysis of Global CTCs Prognostic Technologies Market, by Geography
    3.7 Competitive Landscape
          3.7.1 Global Market Share Analysis, by Key Players, Global CTCs Prognostic Technologies Market, 2013 (Value %)
     
    Chapter 4 Global CTCs Prognostic Technologies Market, by Technology
    4.1 Overview
    4.2 Tumor Cell Enrichment
          4.2.1 Global Tumor Cell Enrichment Market Revenue, 2012 – 2020 (USD Million)
          4.2.2 Filtration
                   4.2.2.1 Global Tumor Cell Enrichment by Filtration Market Revenue, 2012 – 2020 (USD Million)
          4.2.3 Centrifugation
                   4.2.3.1 Global Tumor Cell Enrichment by Centrifugation Market Revenue, 2012 – 2020 (USD Million)
          4.2.4 Immunological and Immunomagnetic Methods
                   4.2.4.1 Global Tumor Cell Enrichment by Immunological and Immunomagnetic Methods Market Revenue, 2012 – 2020 (USD Million)
    4.3 Tumor Cell Detection
          4.3.1 Global Tumor Cell Detection Market Revenue, 2012 – 2020 (USD Million)
          4.3.2 Molecular Methods
                   4.3.2.1 Global Tumor Cell Detection by Molecular Methods Market Revenue, 2012 – 2020 (USD Million)
          4.3.3 Optical Methods
                   4.3.3.1 Global Tumor Cell Detection by Optical Methods Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 5 Global CTCs Prognostic Technologies Market, by Applications
    5.1 Overview
          5.1.1 Global CTCs Prognostic Technologies Market Revenue, by Applications, 2012 – 2020 (USD Million)
    5.2 Prostate Cancer
          5.2.1 Global CTCs Application in Prostate Cancer Market Revenue, 2012 – 2020 (USD Million)
    5.3 Breast Cancer
          5.3.1 Global CTCs Application in Breast Cancer Market Revenue, 2012 – 2020 (USD Million)
    5.4 Colorectal Cancer
          5.4.1 Global CTCs Application in Colorectal Cancer Market Revenue, 2012 – 2020 (USD Million)
    5.5 Others (Lung Cancer, Ovarian Cancer and Pancreatic Cancer)
          5.5.1 Global CTCs Application in Other Cancer Types Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 6 Global CTCs Prognostic Technologies Market, by Geography
    6.1 Overview
          6.1.1 Global CTCs Prognostic Technologies Market Revenue, by Geography, 2012 – 2020 (USD Million)
    6.2 North America
          6.2.1 North America CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
    6.3 Europe
          6.3.1 Europe CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
    6.4 Asia-Pacific
          6.4.1 Asia-Pacific CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
    6.5 Rest of the World (RoW)
          6.5.1 RoW CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 7 Recommendations
     
    Chapter 8 Company Profiles
    8.1 AdnaGen GmbH
          8.1.1 Company Overview
          8.1.2 Financial Overview
          8.1.3 Product Portfolio
          8.1.4 Business Strategies
          8.1.5 Recent Developments
    8.2 Advanced Cell Diagnostics, Inc.
          8.2.1 Company Overview
          8.2.2 Financial Overview
          8.2.3 Product Portfolio
          8.2.4 Business Strategies
          8.2.5 Recent Developments
    8.3 AVIVA Biosciences Corporation
          8.3.1 Company Overview
          8.3.2 Financial Overview
          8.3.3 Product Portfolio
          8.3.4 Business Strategies
    8.4 Celula, Inc.
          8.4.1 Company Overview
          8.4.2 Financial Overview
          8.4.3 Product Portfolio
          8.4.4 Business Strategies
    8.5 Epic Sciences, Inc.
          8.5.1 Company Overview
          8.5.2 Financial Overview
          8.5.3 Product Portfolio
          8.5.4 Business Strategies
          8.5.5 Recent Developments
    8.6 Fluxion Biosciences, Inc.
          8.6.1 Company Overview
          8.6.2 Financial Overview
          8.6.3 Product Portfolio
          8.6.4 Business Strategies
          8.6.5 Recent Developments
    8.7 Rarecells USA, Inc.
          8.7.1 Company Overview
          8.7.2 Financial Overview
          8.7.3 Product Portfolio
          8.7.4 Business Strategies
    8.8 Silicon Biosystems, S.p.A.
          8.8.1 Company Overview
          8.8.2 Financial Overview
          8.8.3 Product Portfolio
          8.8.4 Business Strategies
          8.8.5 Recent Developments
    8.9 Vitatex, Inc.
          8.9.1 Company Overview
          8.9.2 Financial Overview
          8.9.3 Product Portfolio
          8.9.4 Business Strategies
    8.10 Veridex, LLC
          8.10.1 Company Overview
          8.10.2 Financial Overview
          8.10.3 Product Portfolio
          8.10.4 Business Strategies
          8.10.5 Recent Developments
    List of Tables
     
    TABLE 1 Market Snapshot: Global CTCs Prognostic Technologies Market
    TABLE 2 Global CTCs Prognostic Technologies Market Revenue, by Technology, 2012 – 2020 (USD Million)
    TABLE 3 Global Tumor Cell Enrichment Market Revenue, 2012 – 2020 (USD Million)
    TABLE 4 Global Tumor Cell Detection Market Revenue, 2012 – 2020 (USD Million)
    TABLE 5 Global CTCs Prognostic Technologies Market Revenue, by Applications, 2012 – 2020 (USD Million)
    TABLE 6 Global CTCs Prognostic Technologies Market Revenue, by Geography, 2012 – 2020 (USD Million)

    List of Figures

     

    FIG. 1 CTCs Prognostic Technologies: Market Segmentation

    FIG. 2 Global CTCs Prognostic Technologies Market, by Technology, 2012 (USD Million)

    FIG. 3 Global CTCs Prognostic Technologies Market, by Applications, 2012 (USD Million)

    FIG. 4 Comparative Analysis: CTCs Prognostic Technologies Market, by Geography, 2013 & 2020 (Value %)

    FIG. 5 Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Drivers and Restraints

    FIG. 6 Porter’s Five Forces Analysis: Circulating Tumor Cells (CTCs) Prognostic Technologies Market

    FIG. 7 Market Attractiveness Analysis: Global CTCs Prognostic Technologies Market, by Geography

    FIG. 8 Market Share by Key Players: Global CTCs Prognostic Technologies Market, 2013 (Value %)

    FIG. 9 Global Tumor Cell Enrichment by Filtration Market Revenue, 2012 – 2020 (USD Million)

    FIG. 10 Global Tumor Cell Enrichment by Centrifugation Market Revenue, 2012 – 2020 (USD Million)

    FIG. 11 Global Tumor Cell Enrichment by Immunological and Immunomagnetic Methods Market Revenue, 2012 – 2020 (USD Million)

    FIG. 12 Global Tumor Cell Detection by Molecular Methods Market Revenue, 2012 – 2020 (USD Million)

    FIG. 13 Global Tumor Cell Detection by Optical Methods Market Revenue, 2012 – 2020 (USD Million)

    FIG. 14 Global CTCs Application in Prostate Cancer Market Revenue, 2012 – 2020 (USD Million)

    FIG. 15 Global CTCs Application in Breast Cancer Market Revenue, 2012 – 2020 (USD Million)

    FIG. 16 Global CTCs Application in Colorectal Cancer Market Revenue, 2012 – 2020 (USD Million)

    FIG. 17 Global CTCs Application in Other Cancer Types Market Revenue, 2012 – 2020 (USD Million)

    FIG. 18 North America CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)

    FIG. 19 Europe CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)

    FIG. 20 Asia-Pacific CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)

    FIG. 21 RoW CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)

    FIG. 22 Alere, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 23 Menarini Group: Annual Revenue, 2010 – 2012 (USD Million)

    FIG. 24 Johnson & Johnson: Annual Revenue, 2011 – 2013 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved